Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study
Clinical Otolaryngology · 2024
DOI: 10.1111/coa.14167 ↗At a glance
Beobachtungsstudie in Clinical Otolaryngology, 2024. Written by John C Hardman and 10 co-authors. Institution: Head and Neck Unit, The Royal Marsden Hospital, London, UK. Major MEDLINE topics: Neoplasms, Unknown Primary, Squamous Cell Carcinoma of Head and Neck, Head and Neck Neoplasms, Positron Emission Tomography Computed Tomography. Cited 14 times so far (Crossref); 23 references. Funded by: ENT UK Foundation Research Grants Programme.
Abstract (original language)
Introduction
To investigate factors influencing survival in head and neck squamous cell carcinoma of unknown primary (HNSCCUP).
Methods
A retrospective observational cohort study was conducted, over 5 years from January 2015, in UK Head and Neck centres, of consecutive adults undergoing 18F‐Fluorodeoxyglucose‐PET‐CT within 3 months of diagnosis with metastatic cervical squamous cell carcinoma. Patients treated as HNSCCUP underwent survival analysis, stratified by neck dissection and/or radiotherapy to the ipsilateral neck, and by HPV status.
Results
Data were received from 57 centres for 965 patients, of whom 482 started treatment for HNSCCUP (65.7% HPV‐positive, n = 282/429). Five‐year overall survival (OS) for HPV‐positive patients was 85.0% (95% CI 78.4–92.3) and 43.5% (95% CI 32.9–57.5) for HPV‐negative. HPV‐negative status was associated with worse OS, disease‐free (DFS), and disease‐specific (DSS) survival (all p < .0001 on log‐rank test) but not local control (LC) ( p = .16). Unilateral HPV‐positive disease treated with surgery alone was associated with significantly worse DFS ( p < .0001) and LC ( p < .0001) compared to radiotherapy alone or combined modalities (5‐year DFS: 24.9%, 82.3% and 94.3%; 5‐year LC: 41.8%, 98.8% and 98.6%). OS was not significantly different ( p = .16). Unilateral HPV‐negative disease treated with surgery alone was associated with significantly worse LC ( p = .017) (5‐year LC: estimate unavailable, 93.3% and 96.6%, respectively). Small numbers with bilateral disease precluded meaningful sub‐group analysis.
Conclusions
HPV status is associated with variable management and outcomes in HNSCCUP. Unilateral neck disease is treated variably and associated with poorer outcomes when managed with surgery alone. The impact of diagnostic oropharyngeal surgery on primary site emergence, survival and functional outcomes is unestablished.
Subjects
MeSH terms (MEDLINE)
Author keywords
Authors and institutions
- Head and Neck Unit, The Royal Marsden Hospital, London, UK.
- Department of Otolaryngology, Head and Neck Surgery, Gloucestershire Royal Hospital, Gloucester, UK.
- Manchester Royal Infirmary, Manchester Foundation Trust, Manchester, UK.
- Department of Otolaryngology, Head and Neck Surgery, Basildon University Hospital, Basildon, UK.
- Department of Otolaryngology, Head and Neck Surgery, Queen Elizabeth University Hospital, Glasgow, UK.
- Department of Otolaryngology, Head and Neck Surgery, Royal Surrey County Hospital, Guildford, UK.
ORCID profiles: John C Hardman, James Constable, Sian Dobbs, Christopher Hogan, Kate Hulse, Shivun Khosla, Kristijonas Milinis, Ben Tudor-Green, Andrew Williamson, Vinidh Paleri
Funding
- ENT UK Foundation Research Grants Programme
Cite
APA
Hardman, J. C., Constable, J., Dobbs, S., Hogan, C., Hulse, K., Khosla, S., Milinis, K., Tudor-Green, B., Williamson, A., Paleri, V., & INTEGRATE (The UK ENT Trainee Research Network) (2024). Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study. Clinical Otolaryngology. https://doi.org/10.1111/coa.14167
Vancouver
Hardman JC, Constable J, Dobbs S, Hogan C, Hulse K, Khosla S, et al. Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study. Clinical Otolaryngology. 2024. doi:10.1111/coa.14167
BibTeX
@article{Hardman2024,
author = {Hardman, John C and Constable, James and Dobbs, Sian and Hogan, Christopher and Hulse, Kate and Khosla, Shivun and Milinis, Kristijonas and Tudor-Green, Ben and Williamson, Andrew and Paleri, Vinidh and INTEGRATE (The UK ENT Trainee Research Network), INTEGRATE (The UK ENT Trainee Research Network)},
title = {Survival outcomes in head and neck squamous cell carcinoma of unknown primary: A national cohort study},
journal = {Clinical Otolaryngology},
year = {2024},
doi = {10.1111/coa.14167}
}
EUVIMED